Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-29

Clinical Trial Update: Evaluation of Resveratrol and Its Loaded Nanoparticles on Acanthamoeba

View source ↗

Summary

Assiut University is evaluating resveratrol and resveratrol-loaded nanoparticles for Acanthamoeba keratitis, a corneal infection. The trial status is not yet re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Resveratrol (resveratrol)
  • Resveratrol-loaded nanoparticles (resveratrol-loaded nanoparticles)

Snippet

Sponsor: Assiut University | Conditions: Corneal Ulcer Caused by Acanthamoeba | Status: NOT_YET_RECRUITING